Found: 20
Select item for more details and to access through your institution.
Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer - a retrospective analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1374592
- By:
- Publication type:
- Article
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 857, doi. 10.3390/cancers16050857
- By:
- Publication type:
- Article
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42083-4
- By:
- Publication type:
- Article
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42083-4
- By:
- Publication type:
- Article
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases--a phase II study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231600
- By:
- Publication type:
- Article
Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAF<sup>V600E</sup> mutated, microsatellite-stable colon cancer: A case report and literature review.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1166545
- By:
- Publication type:
- Article
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143522
- By:
- Publication type:
- Article
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2459, doi. 10.3390/cancers14102459
- By:
- Publication type:
- Article
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-021-09115-6
- By:
- Publication type:
- Article
Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2091, doi. 10.3390/cancers13092091
- By:
- Publication type:
- Article
A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 6, p. 1452, doi. 10.1002/ijc.33303
- By:
- Publication type:
- Article
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 792, doi. 10.1002/hon.2786
- By:
- Publication type:
- Article
Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2812, doi. 10.3390/cancers12102812
- By:
- Publication type:
- Article
REGO-ACT: assessment of physical activity during treatment with regorafenib for metastatic colorectal cancer.
- Published in:
- Wiener Klinische Wochenschrift, 2020, v. 132, n. 15/16, p. 423, doi. 10.1007/s00508-020-01703-z
- By:
- Publication type:
- Article
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 935, doi. 10.3390/jcm9040935
- By:
- Publication type:
- Article
Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study.
- Published in:
- Integrative Cancer Therapies, 2020, v. 19, p. 1, doi. 10.1177/1534735420938458
- By:
- Publication type:
- Article
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study.
- Published in:
- 2016
- By:
- Publication type:
- journal article